Dong Hua on Clubhouse

Bio

Dr. Dong Hua, Chinese American, founder of Homeopathic Target Health Technology, senior investor, founder, chairman and chief executive officer of ELKONIC. Dr. Hua and his team are committed to the research and development of homeopathic target health technologies, and conduct in-depth research in the field of human cell and gene characteristics.

Earlier he graduated from the Department of Computer Science, University of Science and Technology of China, and received a master's degree in Computer Chinese Medicine (TCM) from the Hong Kong University of Science and Technology, a PhD in Computer Medicine from George Washington University, and a PhD admission in Bioengineering from the University of Illinois at Urbana-Champaign.

华东博士，美籍华人， 顺势靶标健康技术创始人，资深投资人，美国艾尔康宁集团（ELKONIC） 创始人，董事长兼首席执行总裁。华东博士及其艾尔康宁团队致力于顺势靶标健康技术的研究开发工作，围绕人体细胞和基因特性这一领域展开深入研究。
早年毕业于中国科学技术大学计算机科学系，并获得香港科技大学计算机中医(TCM)应用硕士学位、美国乔治华盛顿大学计算机医学应用博士学位和美国伊利诺伊大学香槟分校生物工程博士入学资格。